ES2142547T3 - Derivados de prostaglandina. - Google Patents

Derivados de prostaglandina.

Info

Publication number
ES2142547T3
ES2142547T3 ES96306174T ES96306174T ES2142547T3 ES 2142547 T3 ES2142547 T3 ES 2142547T3 ES 96306174 T ES96306174 T ES 96306174T ES 96306174 T ES96306174 T ES 96306174T ES 2142547 T3 ES2142547 T3 ES 2142547T3
Authority
ES
Spain
Prior art keywords
formula
blood flow
derivatives
prostaglandina
decubitus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96306174T
Other languages
English (en)
Inventor
Akio Nishiura
Takuya Seko
Ryoji Matsumoto
Shin-Ichi Hamano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2142547T3 publication Critical patent/ES2142547T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

DERIVADOS ESTER DE PROSTAGLANDINA E 1 DE FORMULA (I): DONDE LOS GRUPOS R{SUP,1} SON IGUALES ENTRE ELLOS Y SON UN GRUPO ALQUILO C{SUB,4-12}; ASI COMO CLATRATOS DE CICLODEXTRINA. FORMULACIONES LIPOSOMICAS QUE LOS CONTIENE, PROCESOS PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN COMO INGREDIENTE ACTIVO. LOS COMPUESTOS DE FORMULA (I) TIENEN EL EFECTO DE AUMENTAR EL FLUJO SANGUINEO Y SON UTILES EN LA PREVENCION Y/O TRATAMIENTO DE DESORDENES CIRCULATORIOS PERIFERICOS, ULCERAS PO DECUBITO O EN LA PIEL O PARA EL MANTENIMIENTO DEL FLUJO SANGUINEO.
ES96306174T 1995-08-25 1996-08-23 Derivados de prostaglandina. Expired - Lifetime ES2142547T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23898495 1995-08-25

Publications (1)

Publication Number Publication Date
ES2142547T3 true ES2142547T3 (es) 2000-04-16

Family

ID=17038205

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96306174T Expired - Lifetime ES2142547T3 (es) 1995-08-25 1996-08-23 Derivados de prostaglandina.

Country Status (9)

Country Link
US (1) US5698590A (es)
EP (1) EP0760366B1 (es)
KR (1) KR100227541B1 (es)
AT (1) ATE189214T1 (es)
DE (1) DE69606364T2 (es)
DK (1) DK0760366T3 (es)
ES (1) ES2142547T3 (es)
GR (1) GR3033195T3 (es)
PT (1) PT760366E (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5131971B2 (ja) * 2005-12-26 2013-01-30 株式会社Ｌｔｔバイオファーマ 水溶性非ペプチド性低分子薬物含有ナノ粒子
US20100104625A1 (en) * 2007-02-16 2010-04-29 Cornell University Biodegradable compositions and materials
US20100129456A1 (en) * 2007-05-14 2010-05-27 Ltt Bio-Pharma Co., Ltd. Sustained-release nanoparticle containing low-molecular-weight drug with negatively charged group
AU2009246330B2 (en) * 2008-05-14 2015-04-02 Peter Thomas Roth Labs, Llc Prostaglandin based compositions and method of use thereof
AU2010253720A1 (en) * 2009-05-27 2011-12-08 Osaka University Pharmaceutical composition comprising prostaglandin derivatives for use in modulating claudin mediated functions and in the treatment of dermatological disorders
US8569279B2 (en) 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632627A (en) * 1968-01-05 1972-01-04 Smith Kline French Lab Glyceride derivatives of prostaglandins
US4054736A (en) * 1970-06-10 1977-10-18 Ono Pharmaceutical Co., Ltd. Clathrate compounds of prostaglandins or their analogues with cyclodextrin

Also Published As

Publication number Publication date
DK0760366T3 (da) 2000-04-17
DE69606364T2 (de) 2000-06-08
EP0760366A1 (en) 1997-03-05
GR3033195T3 (en) 2000-08-31
PT760366E (pt) 2000-07-31
KR970010743A (ko) 1997-03-27
EP0760366B1 (en) 2000-01-26
KR100227541B1 (ko) 1999-11-01
ATE189214T1 (de) 2000-02-15
US5698590A (en) 1997-12-16
DE69606364D1 (de) 2000-03-02

Similar Documents

Publication Publication Date Title
ATE237324T1 (de) Dexanabinol-derivate und ihre verwendung als neuroprotektive pharmazeutische zusammensetzungen
FR2680366B1 (fr) Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FR2422634A1 (fr) Isosteres de type 9-desoxy-9a-methylene de pgi2, utiles comme medicaments, et leur procede de preparation
FI872864A (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
KR890003382A (ko) 항 비루스성 화합물
ATE185559T1 (de) Prostaglandin-derivate
DE68906609D1 (de) Dopamin-vorlaeufer.
ES2051479T3 (es) Uso de imidazoles substituidos en 4 para disminuir la presion intraocular.
TNSN87012A1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
DE60019086D1 (de) Zusammensetzungen zur behandlung von hautkrankheiten
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
ES2142547T3 (es) Derivados de prostaglandina.
FR2415636A1 (fr) Nouveaux derives de la guanidine, leur preparation et leur application comme medicaments
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные
ES2134441T3 (es) Benzonitrilos terapeuticos.
DE3585070D1 (de) Tetrahydro-1,2,4-oxadiazin-5-thion-derivate.
FR2414333A2 (fr) Composition pharmaceutique contenant comme ingredient actif la d-2-bromo 6-methyl-8b-(morpholinocarbonyoxymethyl)-ergoline, utile notamment pour le traitement de l'asthme
ITMI930273A0 (it) Composti terapeuticamente attivi, utili per il trattamento di malattie connesse con alterata funzionalita' del sistema immunitario procedimento per la loro preparazione e composizione farmaceutiche che li contengono
ITMI913461A1 (it) Composizioni terapeutiche adatte per la somministrazione rettale contenenti come principio attivo uno o piu' tioesteri del glutatione

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 760366

Country of ref document: ES